Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)

Ryan Orgel, Daniel Wojdyla, David Huberman, Jonathan L Halperin, Günter Breithardt, Daniel E Singer, Keith A A Fox, Graeme J Hankey, Kenneth W Mahaffey, W Schuyler Jones, Manesh R Patel

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCirculation: Cardiovascular Quality and Outcomes
Volume10
Issue number5
DOIs
Publication statusPublished - 11 May 2017

Keywords

  • Journal Article

Cite this